A carregar...
Higher Risk of Hospitalization and Serious Infection Among Patients With Ulcerative Colitis Treated with Adalimumab, Compared with Infliximab, in a Nationwide Study
BACKGROUND & AIMS: We compared the effectiveness and safety of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis (UC), in a nationwide register-based propensity score-matched study of patients in Denmark. METHODS: We collected data from 1719 adults with UC, 15–75 years...
Na minha lista:
Publicado no: | Clin Gastroenterol Hepatol |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5447492/ https://ncbi.nlm.nih.gov/pubmed/27913244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2016.11.024 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|